Search Results - "De Martino, Michela"

Prognostic impact of preoperative neutrophil-to-lymphocyte ratio in localized nonclear cell renal cell carcinoma by de Martino, Michela, Pantuck, Allan J, Hofbauer, Sebastian, Waldert, Matthias, Shariat, Shahrokh F, Belldegrun, Arie S, Klatte, Tobias

“…The preoperative neutrophil-to-lymphocyte ratio was proposed as a prognostic factor for localized clear cell renal cell carcinoma. We evaluated its role in…”
Get more information

Serum cell‐free DNA in renal cell carcinoma by de Martino, Michela, Klatte, Tobias, Haitel, Andrea, Marberger, Michael

“…BACKGROUND: Currently, there are no established diagnostic and prognostic serum markers for renal cell carcinoma (RCC). The objective of this study was to…”
Get full text

Comparison of the prognostic value of pretreatment measurements of systemic inflammatory response in patients undergoing curative resection of clear cell renal cell carcinoma by Lucca, Ilaria, de Martino, Michela, Hofbauer, Sebastian L., Zamani, Nura, Shariat, Shahrokh F., Klatte, Tobias

“…Purpose Pretreatment measurements of systemic inflammatory response, including the Glasgow prognostic score (GPS), the neutrophil-to-lymphocyte ratio (NLR),…”
Get full text

A urinary microRNA (miR) signature for diagnosis of bladder cancer by Hofbauer, Sebastian L., de Martino, Michela, Lucca, Ilaria, Haitel, Andrea, Susani, Martin, Shariat, Shahrokh F., Klatte, Tobias

“…•Urinary microRNA-based signature predicts the presence of bladder cancer.•Prediction independent of stage and grade.•High consistency with previous work in…”
Get full text

Cytogenetic Profile Predicts Prognosis of Patients With Clear Cell Renal Cell Carcinoma by KLATTE, Tobias, NAGESH RAO, P, DE MARTINO, Michela, LAROCHELLE, Jeffrey, SHUCH, Brian, ZOMORODIAN, Nazy, SAID, Jonathan, KABBINAVAR, Fairooz F, BELLDEGRUN, Arie S, PANTUCK, Allan J

“…The majority of cytogenetic studies in renal cell carcinoma (RCC) have been impaired by small sample size, retrospective character, and lack of a survival end…”
Get full text

The protease activated receptor 1 gene variation IVSn -14 A>T is associated with distant metastasis and cancer specific survival in renal cell carcinoma by de Martino, Michela, Haitel, Andrea, Schatzl, Georg, Klatte, Tobias

“…PAR-1 mediates angiogenesis and impacts the process of tumor growth and disease progression. We evaluated the associations of the gene variations PAR-1 IVSn…”
Get more information

Single-Cell Analysis of the Dps Response to Oxidative Stress by De Martino, Michela, Ershov, Dmitry, van den Berg, Peter J, Tans, Sander J, Meyer, Anne S

“…Microorganisms have developed an elaborate spectrum of mechanisms to respond and adapt to environmental stress conditions. Among these is the expression of…”
Get full text

The preoperative prognostic nutritional index is an independent predictor of survival in patients with renal cell carcinoma by Hofbauer, Sebastian L., M.D, Pantuck, Allan J., M.D, de Martino, Michela, Ph.D, Lucca, Ilaria, M.D, Haitel, Andrea, M.D, Shariat, Shahrokh F., M.D, Belldegrun, Arie S., M.D, Klatte, Tobias, M.D

“…Abstract Objective Accurate postoperative stratification of patients with renal cell carcinoma (RCC) in distinct prognostic groups is essential for tailoring…”
Get full text

PD-L1 expression in tumor and inflammatory cells is associated with favorable tumor features and favorable prognosis in muscle-invasive urothelial carcinoma of the bladder not treated by immune checkpoint inhibitors by Plage, Henning, Furlano, Kira, Hofbauer, Sebastian, Weinberger, Sarah, Ralla, Bernhard, Franz, Antonia, Fendler, Annika, de Martino, Michela, Roßner, Florian, Elezkurtaj, Sefer, Kluth, Martina, Lennartz, Maximilian, Blessin, Niclas C, Marx, Andreas H, Samtleben, Henrik, Fisch, Margit, Rink, Michael, Slojewski, Marcin, Kaczmarek, Krystian, Ecke, Thorsten, Hallmann, Steffen, Koch, Stefan, Adamini, Nico, Zecha, Henrik, Minner, Sarah, Simon, Ronald, Sauter, Guido, Weischenfeldt, Joachim, Klatte, Tobias, Schlomm, Thorsten, Horst, David, Schallenberg, Simon

“…A high level of PD-L1 expression is the most relevant predictive parameter for response to immune checkpoint inhibitor (CPI) therapy in urinary bladder cancer…”
Get full text

Management and outcome of bilateral testicular germ cell tumors: A 25-year single center experience by Klatte, Tobias, de Martino, Michela, Arensmeier, Knut, Reiher, Frank, Allhoff, Ernst P, Klatte, Detlef

“…Objectives:  To analyze risk factors, management, histology, and outcome of bilateral testicular germ cell tumors (TGCT) based on a 25‐year single center…”
Get full text

The role of adjuvant chemotherapy for lymph node‐positive upper tract urothelial carcinoma following radical nephroureterectomy: a retrospective study by Lucca, Ilaria, Kassouf, Wassim, Kapoor, Anil, Fairey, Adrian, Rendon, Ricardo A., Izawa, Jonathan I., Black, Peter C., Fajkovic, Harun, Seitz, Christian, Remzi, Mesut, Nyirády, Peter, Rouprêt, Morgan, Margulis, Vitaly, Lotan, Yair, Martino, Michela, Hofbauer, Sebastian L., Karakiewicz, Pierre I., Briganti, Alberto, Novara, Giacomo, Shariat, Shahrokh F., Klatte, Tobias

“…Objective To evaluate the effect of adjuvant chemotherapy (AC) on mortality after radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC)…”
Get full text

Features and outcomes of renal cell carcinoma of native kidneys in renal transplant recipients by Klatte, Tobias, Seitz, Christian, Waldert, Matthias, De Martino, Michela, Kikic, Željko, Böhmig, Georg A., Haitel, Andrea, Schmidbauer, Jörg, Marberger, Michael, Remzi, Mesut

“…Study Type – Therapy (case series)
Level of Evidence 4 OBJECTIVE To outline the features and outcomes of renal cell carcinoma (RCC) in native kidneys of renal…”
Get full text

Novel Biomarkers to Predict Response and Prognosis in Localized Bladder Cancer by Lucca, Ilaria, MD, de Martino, Michela, PhD, Klatte, Tobias, MD, Shariat, Shahrokh F., MD

“…This review summarizes recent developments in diagnostic and prognostic biomarkers for nonmuscle invasive bladder cancer (NMIBC). Although the number of new…”
Get full text

Effect of ABO blood type on mortality in patients with urothelial carcinoma of the bladder treated with radical cystectomy by Klatte, Tobias, M.D, Xylinas, Evanguelos, M.D, Rieken, Malte, M.D, Rouprêt, Morgan, M.D, Fajkovic, Harun, M.D, Seitz, Christian, M.D, Karakiewicz, Pierre I., M.D, Lotan, Yair, M.D, Babjuk, Marko, M.D, de Martino, Michela, Ph.D, Shariat, Shahrokh F., M.D

“…Abstract Objective ABO blood type is an inherited characteristic that has been associated with the prognosis of several malignancies, but there is little…”
Get full text

1H-NMR metabolomics reveals the Glabrescione B exacerbation of glycolytic metabolism beside the cell growth inhibitory effect in glioma by D'Alessandro, Giuseppina, Quaglio, Deborah, Monaco, Lucia, Lauro, Clotilde, Ghirga, Francesca, Ingallina, Cinzia, De Martino, Michela, Fucile, Sergio, Porzia, Alessandra, Di Castro, Maria Amalia, Bellato, Federica, Mastrotto, Francesca, Mori, Mattia, Infante, Paola, Turano, Paola, Salmaso, Stefano, Caliceti, Paolo, Di Marcotullio, Lucia, Botta, Bruno, Ghini, Veronica, Limatola, Cristina

“…Glioma is the most common and primary brain tumors in adults. Despite the available multimodal therapies, glioma patients appear to have a poor prognosis. The…”
Get full text

Prognostic role of ERCC1 protein expression in upper tract urothelial carcinoma following radical nephroureterectomy with curative intent by Mbeutcha, Aurélie, Lucca, Ilaria, Margulis, Vitaly, Karam, Jose A., Wood, Christopher G., de Martino, Michela, Mathieu, Romain, Haitel, Andrea, Xylinas, Evanguelos, Kluth, Luis, Rouprêt, Morgan, Karakiewicz, Pierre I., Briganti, Alberto, Rink, Michael, Rieken, Malte, Weizer, Alon Z., Raman, Jay D., Rioux-Leclecq, Nathalie, Bolenz, Christian, Bensalah, Karim, Lotan, Yair, Seitz, Christian, Remzi, Mesut, Shariat, Shahrokh F., Klatte, Tobias

“…Background Excision repair cross-complementing 1 (ERCC1) has been associated with outcomes of urothelial carcinoma of the bladder, but was not yet studied in…”
Get full text

JAK3 in clear cell renal cell carcinoma: Mutational screening and clinical implications by de Martino, Michela, Ph.D, Gigante, Maddalena, Ph.D, Cormio, Luigi, M.D, Prattichizzo, Clelia, Ph.D, Cavalcanti, Elisabetta, Ph.D, Gigante, Margherita, Ph.D, Ariano, Vincenzo, M.D, Netti, Giuseppe S., M.D, Montemurno, Eustacchio, B.S, Mancini, Vito, M.D, Battaglia, Michele, M.D, Gesualdo, Loreto, M.D, Carrieri, Giuseppe, M.D, Ranieri, Elena, Ph.D

“…Abstract Objectives Janus Kinase 3 ( JAK3 ) mediates cytokine signaling and T-cell activation. We hypothesized that JAK3 mutations may contribute to the…”
Get full text

Standard requirements for randomized controlled trials in surgery by Zonta, Sandro, MD, De Martino, Michela, MD

Get full text

Carbonic anhydrase IX in bladder cancer by Klatte, Tobias, Seligson, David B., Rao, Jian Yu, Yu, Hong, de Martino, Michela, Kawaoka, Kelly, Wong, Steven G., Belldegrun, Arie S., Pantuck, Allan J.

“…BACKGROUND: The objective of this study was to evaluate the role of carbonic anhydrase IX (CAIX) in urothelial carcinoma of the bladder. METHODS: A tissue…”
Get full text

Serum Cell-Free DNA in Renal Cell Carcinoma: A Diagnostic and Prognostic Marker by DE MARTINO, Michela, KLATTE, Tobias, HAITEL, Andrea, MARBERGER, Michael

“…Currently, there are no established diagnostic and prognostic serum markers for renal cell carcinoma (RCC). The objective of this study was to evaluate the…”
Get full text